* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Hospital brochure - LMA™ Better by design
Survey
Document related concepts
Epinephrine autoinjector wikipedia , lookup
Orphan drug wikipedia , lookup
Compounding wikipedia , lookup
Psychopharmacology wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Neuropharmacology wikipedia , lookup
Drug design wikipedia , lookup
Pharmacognosy wikipedia , lookup
Drug discovery wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Nicholas A. Peppas wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Transcript
No needle. No trauma. Needle-free intranasal drug delivery device The unique design of LMA MAD Nasal™ enables a seal to be formed with the nostril and atomized particles of medication to be delivered to the nasal mucosa. The particles are then absorbed through the mucosal tissue and into the bloodstream, avoiding first pass metabolism. Atomization spray Soft conical plug The spray atomizes drugs into a fine mist of particles 30-100 microns in size. Malleable stylet The plug forms a seal with the nostril preventing expulsion of fluid. The malleable stylet allows 180° positioning of the nasal plug. Accurate dosing The syringe enables the accurate measurement of drugs to be delivered. Pressure High applied pressure ensures that drugs are atomized into a fine mist of particles through the tip of the plug. Managing time critical emergency situations Intranasal drug delivery with LMA MAD Nasal™ can be carried out by a broad range of healthcare professionals and is an effective alternative drug delivery method, for use with drugs approved for nasal delivery. Needle-free drug delivery device User-friendly device LMA MAD Nasal™ decreases the chances of accidental needlestick injuries both on scene and while managing patients during transport. LMA MAD Nasal™ is an easy and effective drug delivery device, which enables users to deliver medication directly into the nose from any angle. Eliminates risk of needlestick injury in drug delivery At the point of drug delivery, LMA MAD Nasal™ eliminates the risk of needlestick injuries. There are a number of benefits associated with needle-free drug delivery: A ddresses concerns over blood-borne pathogens A broader scope of healthcare workers can deliver drugs intranasally without having to access a vein R educes costs associated with needlestick injury R educes time spent reporting and processing needlestick injuries Risk free from needlestick injury at the point of drug delivery. R educes the amount of time off work due to needlestick injury Time efficient drug delivery LMA MAD Nasal™ can deliver time efficiencies in clinical practice, leaving more time to focus on patient care. LMA MAD Nasal™ enables healthcare professionals to: S pend less time preparing an IV line Quickly and effectively prepare a dose for IN drug delivery S pend less time delivering drugs intravenously Administer medication rapidly via the intranasal mucosa LMA MAD Nasal™: Product specification PO number Quantity / case Quantity / box Description MAD100 100 25 Intranasal mucosal atomization device with 3ml syringe MAD100OS 100 25 Intranasal mucosal atomization device with 3ml oral syringe MAD110 100 25 Intranasal mucosal atomization device with 1ml syringe MAD110OS 100 25 Intranasal mucosal atomization device with 1ml oral syringe MAD130 100 25 Intranasal mucosal atomization device with 1ml syringe and vial adaptor MAD130OS 100 25 Intranasal mucosal atomization device with 1ml oral syringe and vial adaptor MAD140 100 25 Intranasal mucosal atomization device with 3ml syringe and vial adapter MAD140OS 100 25 Intranasal mucosal atomization device with 3ml oral syringe and vial adaptor MAD300 100 25 Intranasal mucosal atomization device without syringe Find out more about LMA MAD Nasal ™ Clinical evidence For the latest clinical evidence on LMA MAD Nasal™ and LMA Atomization™, visit www.lmaco.com/evidence For the latest digital case reports, educational videos and clinician testimonials on the benefits of LMA MAD Nasal™ and LMA Atomization™, visit www.youtube.com/LaryngealMaskAirway For the latest news from LMA, like us on www.facebook.com/LMAInternational For product information and access to product instructions for use, visit www.lmaco.com For information on other products within the Teleflex product portfolio, visit www.teleflex.com TELEFLEX HEADQUARTERS INTERNATIONAL, IRELAND Teleflex Medical Europe Ltd., IDA Business and Technology Park, Dublin Road, Athlone, Co. Westmeath, Ireland Phone +353 (0)9 06 46 08 00 Fax +353 (0)14 37 07 73 [email protected] 30-0309 Rev. 10/14 Distributed by: Teleflex www.teleflex.com LMA www.lmaco.com Manufactured by: Wolfe Tory Medical, Inc. 79 West 4500 South Salt Lake City, Utah 84107 Consult IFU on this website: www.LMACO.com For use with drugs approved for nasal delivery. Copyright © 2014 Teleflex Incorporated. All rights reserved. LMA, LMA Atomization, LMA Better by Design, LMA MAD Nasal, LMA MAD, MAD and MAD Nasal are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. Wolfe-Tory Medical, Inc. is a wholly owned subsidiary of Teleflex Medical. XX XX XX – XX XX XX . XXX XX/XX . XX/X . XX XX XX